Friday, July 10, 2026

pharma · Hepatitis B, Chronic · Cancer

EmeraMed

EmeraMed clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Ranelagh, IE HQ
2007 Founded
7 Employees
EMA registrant Type
Company details
Status
Public
HQ
Ranelagh, IE
Founded
2007
Employees
7
Programs
5
Drugs
9
Patents
0
Intelligence · Clinical Programs

EmeraMed projects

3 ClinicalTrials.gov programs sponsored by EmeraMed.

EmeraMed has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. IMC-M113V

    Immunocore Ireland Limited

    Chronic HIV infection

    phase 2 small molecule active

    1 trial
  2. IMC-R117C

    Immunocore Ireland Limited

    Cancer

    phase 2 small molecule active

    1 trial
  3. IMCgp100-202

    Immunocore Ireland Limited

    Previously untreated advanced uveal melanoma (UM)

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does EmeraMed have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.